Navigation Links
UBC professor wins Canada's top pharmaceutical research award
Date:11/19/2012

UBC microbiologist Robert E.W. Hancock has received the Prix Galien 2012 Research Award, widely considered the most prestigious honour in Canadian pharmaceutical research and innovation. Hancock is being recognized for pioneering work unravelling the complex interactions between antibiotics and bacteria.

"The Prix Galien is a testament to Bob Hancock's profound impact on Canadian health research," said Simon Peacock, Dean of UBC's Faculty of Science. "His research focuses on the growing challenge of antibiotic resistance and has resulted in new therapeutic approaches to infectious diseases, like malaria."

Hancock is a leader in Canadian health research, focusing on the prevention and treatment of infectious disease. At UBC he established the Centre for Microbial Diseases and Immunity Research (CMDR) and also co-founded the Centre for Drug Research and Development (CDRD), a national not-for-profit drug development and commercialization centre.

Hancock's research interests include antibiotic uptake and resistance, cationic peptides as novel antimicrobials, innate immunity, and bacterial genomics. His breakthrough discovery of a novel way of selectively modulating immunity and suppressing harmful inflammation while retaining protective immunity has, according to Prix Galien Canada, the potential to revolutionize human healthcare.


'/>"/>

Contact: Silvia Moreno-Garcia
silvia.moreno-garcia@science.ubc.ca
604-822-5001
University of British Columbia
Source:Eurekalert

Page: 1

Related medicine news :

1. Guys, take note: Male birth control pill may be ready soon, says Texas A&M professor
2. IHME professor named first health measurement winner of prestigious innovation award
3. From textbook to flexbook: Professor uses new collaborative tool in the classroom
4. President Obama names SF State math professor a top young scientist
5. Women professorships low in some Scandinavian universities due to sexism
6. Louisiana Tech biomedical engineering professor earns recognition, funding for research
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. Louisiana Tech University professor earns NSF Early Career Development grant
9. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology: